ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

NMRA Neumora Therapeutics Inc

9.69
0.02 (0.21%)
2024年5月21日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Neumora Therapeutics Inc NMRA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.02 0.21% 9.69 08:44:57
始値 安値 高値 終値 前日終値
9.70 9.29 9.74 9.69 9.67
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/1420:00GLOBENeumora Therapeutics Announces Initiation of Phase 2 Study..
2024/5/0805:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0720:15EDGAR2Form 8-K - Current report
2024/5/0720:00GLOBENeumora Therapeutics Reports First Quarter 2024 Financial..
2024/5/0620:00GLOBENeumora Therapeutics to Participate in Upcoming Conferences..
2024/4/1519:30GLOBENeumora Therapeutics Announces Clinical Hold of Phase 1..
2024/3/1320:00GLOBENeumora Therapeutics to Participate at Stifel 2024 Virtual..
2024/3/0806:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0721:08EDGAR2Form 8-K - Current report
2024/3/0721:00GLOBENeumora Therapeutics Reports Fourth Quarter and Full Year..
2024/2/1706:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1706:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1706:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1706:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2221:00GLOBENeumora Therapeutics Appoints Kaya Pai Panandiker as Chief..
2024/1/0822:32EDGAR2Form 8-K - Current report
2024/1/0221:00GLOBENeumora Therapeutics to Present at 42nd Annual J.P. Morgan..
2023/12/1607:06EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/12/1221:00GLOBENeumora Therapeutics Appoints Jason Duncan as Chief Legal..
2023/11/2906:21EDGAR2Form 8-K - Current report
2023/11/2721:00GLOBENeumora Therapeutics Announces NMRA-266 IND Clearance and..
2023/11/0205:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0205:01EDGAR2Form 8-K - Current report
2023/11/0120:00GLOBENeumora Therapeutics Reports Third Quarter 2023 Financial..
2023/10/3020:00GLOBENeumora Therapeutics to Participate in Upcoming Conferences..
2023/10/1020:00GLOBENeumora Therapeutics Announces Appointment of Robert Lenz,..
2023/9/1509:49GLOBENeumora Therapeutics Announces Pricing of Initial Public..

最近閲覧した銘柄